Skip to content
← Lobby register
ET
Other

Elusys Therapeutics, Inc

🇪🇺 UNITED STATESRegistered 21/12 staff
Disclosed budget
€10,000 — €24,999
Meetings 12mo
0
Policy files
21
Accredited passes
0

Recent meetings

No recorded meetings with EU commissioners.

Mission & Goals

Biodefense and health security preparedness and advocacy

EU Legislative Interests

Healthcare, health security, and biodefense related legislation

Communication Activities

No current communication activities, previous updates can be found here: https://elusys.com/news-media. Previously, held European Union - EMA marketing authorization for Obiltoxaximab, an Anthrax antitoxin, which included marketing, regulatory, and communications activities in Europe and with the European Union representatives about this product.

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

Biotechnology Innovation Organization

Organisation Members

No other EU memberships

Connected Legislation